Use of Epigenetic Cell Counting to Determine the Effect of Ozanimod on Circulating Leukocyte Subtypes in Patients With Relapsing Multiple Sclerosis Carlos Bonilla2021-12-06T11:29:50-05:00Resources| Read More
Effects on CD3, Treg, and TH17 Cell Numbers in Skin Biopsies After 16-Week Mirikizumab Treatment, Evaluated by an Epigenetic Assay Carlos Bonilla2021-11-29T17:36:51-05:00Resources| Read More
Etrolizumab Treatment Increases Blood Levels of CD3, Treg and Th17 Cells Measured Through Epigenetic Activation of CD3, FOXP3 and IL-17 Loci Carlos Bonilla2021-12-06T11:27:52-05:00Resources| Read More
In Vivo Maintenance of Human Regulatory T Cells During CD25 Blockade Carlos Bonilla2021-11-29T17:26:25-05:00Resources| Read More
